PROBUPHINE Trademark

Trademark Overview

On Wednesday, August 18, 2010, a trademark application was filed for PROBUPHINE with the United States Patent and Trademark Office. The USPTO has given the PROBUPHINE trademark a serial number of 85110551. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, June 25, 2022. This trademark is owned by Titan Pharmaceuticals, Inc.. The PROBUPHINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
probuphine

General Information

Serial Number85110551
Word MarkPROBUPHINE
Filing DateWednesday, August 18, 2010
Status800 - REGISTERED AND RENEWED
Status DateSaturday, June 25, 2022
Registration Number4102980
Registration DateTuesday, February 21, 2012
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2011

Trademark Statements

Goods and ServicesPharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 24, 2010
Primary Code005
First Use Anywhere DateThursday, April 22, 2010
First Use In Commerce DateThursday, April 22, 2010

Trademark Owner History

Party NameREACX PHARMACEUTICALS, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameFEDSON, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCHARLOTTESVILLE, VA 22901
Party NameTitan Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940801958
Party NameTitan Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940801921
Party NameTitan Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940801921

Trademark Events

Event DateEvent Description
Saturday, August 21, 2010NEW APPLICATION ENTERED
Tuesday, August 24, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 3, 2010ASSIGNED TO EXAMINER
Wednesday, December 8, 2010NON-FINAL ACTION WRITTEN
Wednesday, December 8, 2010NON-FINAL ACTION MAILED
Thursday, March 3, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 3, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 4, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 18, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 2, 2011ASSIGNED TO LIE
Saturday, April 2, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 20, 2011NOTICE OF PUBLICATION
Tuesday, May 10, 2011PUBLISHED FOR OPPOSITION
Tuesday, July 5, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 9, 2011TEAS STATEMENT OF USE RECEIVED
Friday, December 9, 2011USE AMENDMENT FILED
Friday, December 30, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 4, 2012STATEMENT OF USE PROCESSING COMPLETE
Friday, January 13, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 13, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, January 14, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Tuesday, February 21, 2012REGISTERED-PRINCIPAL REGISTER
Thursday, December 12, 2013TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, December 19, 2013REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Tuesday, March 7, 2017TEAS SECTION 8 & 15 RECEIVED
Thursday, April 27, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 27, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, April 27, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, March 28, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sunday, February 21, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, January 18, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, June 25, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, June 25, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, June 25, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, June 25, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, September 20, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 21, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 21, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 21, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 21, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 21, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 13, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, June 13, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 13, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

probuphine system formulation matrix pharmaceuticals release treatment drugs based sustained implantable